Trial Outcomes & Findings for Evaluation of PSMA Antagonist Produced by Two Different Methods (NCT NCT04685811)

NCT ID: NCT04685811

Last Updated: 2022-09-22

Results Overview

Single score Intraclass Correlation Coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying pathologic lesions. The ICC, based on a one-way random effects model was used to assess reliability. The ICC ratios in this data shows the top five lesions with the greatest PSMA uptake (SUV) in each patient. This is a measure of the variance of interest (for the patient's lesion) over the total variance (from all data points for that particular lesion of interest). Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The lesions reported in this analysis range from the SUV of reference organs to the average SUV of a metastatic deposit. These scans were also performed within 48 hours of each other to limit heterogeneity that may correspond to disease progression or PSMA avidity.

Recruitment status

COMPLETED

Study phase

PHASE1/PHASE2

Target enrollment

16 participants

Primary outcome timeframe

2 study visits between 24 to 48 hours apart

Results posted on

2022-09-22

Participant Flow

Participant milestones

Participant milestones
Measure
Generator PSMA Scan vs Cyclotron PSMA Scan
Intraclass Correation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax. Patients with metastatic prostate adenocarcinoma were administered a single intravenous dose approximately 100-300mBq of each of the study drugs 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator 24- 48 hours apart. Intervention Description: 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator; single dose each, approximately 100-300 mBq
Overall Study
STARTED
16
Overall Study
COMPLETED
16
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of PSMA Antagonist Produced by Two Different Methods

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ICC Between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
Age, Continuous
73 years
n=99 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
Sex: Female, Male
Male
16 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=99 Participants
Race (NIH/OMB)
White
14 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
16 participants
n=99 Participants

PRIMARY outcome

Timeframe: 2 study visits between 24 to 48 hours apart

Single score Intraclass Correlation Coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying pathologic lesions. The ICC, based on a one-way random effects model was used to assess reliability. The ICC ratios in this data shows the top five lesions with the greatest PSMA uptake (SUV) in each patient. This is a measure of the variance of interest (for the patient's lesion) over the total variance (from all data points for that particular lesion of interest). Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The lesions reported in this analysis range from the SUV of reference organs to the average SUV of a metastatic deposit. These scans were also performed within 48 hours of each other to limit heterogeneity that may correspond to disease progression or PSMA avidity.

Outcome measures

Outcome measures
Measure
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 1
0.98 ICC estimate
Interval 0.94 to 0.99
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 2
0.98 ICC estimate
Interval 0.95 to 0.99
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 3
0.99 ICC estimate
Interval 0.96 to 1.0
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 4
0.99 ICC estimate
Interval 0.96 to 1.0
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 5
0.97 ICC estimate
Interval 0.91 to 0.99

PRIMARY outcome

Timeframe: 2 study visits between 24 to 48 hours apart

Single score intraclass correlation coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying average SUV Max-pathologic regions The ICC ratios in this data provides a general performance review of uptake in both pathological lesions and reference lesions, specifically the average SUVmax of bone metastases, lymph nodes, salivary glands, and the spleen.

Outcome measures

Outcome measures
Measure
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Bone Lesions
0.96 ICC estimate
Interval 0.88 to 0.99
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Lymph Nodes
0.86 ICC estimate
Interval 0.62 to 0.95
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Salivary Glands and Parotids
0.70 ICC estimate
Interval 0.34 to 0.88
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Spleen
0.82 ICC estimate
Interval 0.57 to 0.93

PRIMARY outcome

Timeframe: 2 study visits between 24 to 48 hours apart

Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The intraclass correlation coefficient (ICC), based on a one-way random effects model (i.e., assumes subjects are randomly selected from the larger population), was used to assess reliability between generator and cyclotron scanning methods. BlandAltman analysis evaluated the agreement between the two scanning methods. Confidence levels of 95% were estimated to assess precision of the obtained estimates. All analyses were performed in R Version 4.0.5 (R Foundation for Statistical Computing, Vienna, Austria).

Outcome measures

Outcome measures
Measure
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
ICC Between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
0.97 ICC estimate

SECONDARY outcome

Timeframe: 2 study visits between 24 to 48 hours apart

Single score intraclass correlation coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying Max SUV -pathologic regions Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The intraclass correlation coefficient (ICC), based on a one-way random effects model (i.e., assumes subjects are randomly selected from the larger population), was used to assess reliability between generator and cyclotron scanning methods. BlandAltman analysis evaluated the agreement between the two scanning methods. Confidence levels of 95% were estimated to assess precision of the obtained estimates. All analyses were performed in R Version 4.0.5 (R Foundation for Statistical Computing, Vienna, Austria).

Outcome measures

Outcome measures
Measure
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Aorta
0.59 ICC estimate
Interval 0.17 to 0.84
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Liver
0.91 ICC estimate
Interval 0.76 to 0.97
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Parotid
0.78 ICC estimate
Interval 0.48 to 0.92

SECONDARY outcome

Timeframe: 2 study visits between 24 to 48 hours apart

The biodistribution of 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator will be evaluated by measuring the radioactivity concentration in various organs of interest. Based on the SUVmean and SUVmax, the RC unit will be used to compare these scans. PSMA positivity was defined as having a SUV value above that of the reference blood pool, liver, and/or salivary glands when evaluating lesions as described using the PROMISE criteria15. Quantitative analysis reviewed the SUVmax and SUVmean of the parotid gland, liver, and aortic arch (blood pool), as well as the SUVmax and SUVmean of suspected metastatic lesions. The same ROIs were evaluated on both scans for each respective patients.

Outcome measures

Outcome measures
Measure
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average Coefficient Variation
0.97 ICC estimate
Interval 0.92 to 0.99
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average Standard Deviation
0.94 ICC estimate
Interval 0.85 to 0.98
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average SUV Max
0.97 ICC estimate
Interval 0.91 to 0.99
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average SUV Mean
0.71 ICC estimate
Interval 0.36 to 0.89

Adverse Events

Generator PSMA Scan vs Cyclotron PSMA Scan

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Juana Martinez Zuloaga

Weill Cornell Medical College

Phone: 212-746-6000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place